Keyoung Hansoo Michael 4
4 · GRAYBUG VISION, INC. · Filed Sep 29, 2020
Insider Transaction Report
Form 4
Keyoung Hansoo Michael
Director
Transactions
- Conversion
Series C Preferred Stock
2020-09-29−1,133,596→ 0 total(indirect: See footnote)→ Common Stock (1,133,596 underlying) - Conversion
Common Stock
2020-09-29+1,133,596→ 1,133,596 total(indirect: See footnote)
Footnotes (2)
- [F1]Each share of the Issuer's Series C Preferred Stock automatically converted into 1 share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date.
- [F2]These securities are held of record by AffaMed Project Limited ("AffaMed"). Mengjiao Jiang and the Reporting Person are the directors of AffaMed and each of them may be deemed to hold shared voting and dispositive power with respect to the shares held by AffaMed. The Reporting Person disclaims beneficial ownership of the securities held by AffaMed except to the extent of his pecuniary interest therein, if any.